CD8A and neoplasm: This apCAF-mediated chemical chemotactic network synergizes with ECM remodeling, not only blocking the physical infiltration of CD8+ T cells, but also further strengthening immunosuppression by secreting proinflammatory factors, forming a “multi-layer barrier” to help tumor immune escape and treatment resistance.